DRI Healthcare Trust Net Assets
DRI Healthcare Trust net assets. Based on the latest financial reports, DRI Healthcare Trust (DHT-U) has net assets worth $503.60 Million USD as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($967.26 Million) and total liabilities ($463.66 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore DHT-U shareholders equity momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $503.60 Million |
| % of Total Assets | 52.06% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 25.85 |
Net Assets of DRI Healthcare Trust (2020–2024)
Net assets of DRI Healthcare Trust from 2020 to 2024. This chart illustrates how DRI Healthcare Trust's net assets have evolved over time, based on quarterly financial data. See DHT-U equity financing ratio to measure how much of total assets are equity-financed.
Annual Net Assets for DRI Healthcare Trust (2020–2024)
The table below shows the annual net assets of DRI Healthcare Trust from 2020 to 2024. For live market cap and overall valuation, see DRI Healthcare Trust (DHT-U) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $527.53 Million | -6.05% |
| 2023-12-31 | $561.50 Million | +50.80% |
| 2022-12-31 | $372.34 Million | -1.75% |
| 2021-12-31 | $378.99 Million | +107666293.18% |
| 2020-12-31 | $-352.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to DRI Healthcare Trust's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2714163800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
DRI Healthcare Trust Net Assets Breakdown (December 2024)
DRI Healthcare Trust net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $554.67 Million | 105.15% |
| Total Equity | $527.53 Million | 100.00% |
DRI Healthcare Trust Competitors by Market Cap
The table below lists competitors of DRI Healthcare Trust ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shenzhen Guangju Energy Co Ltd
SHE:000096
|
$594.15 Million |
|
Rezolve AI Limited Ordinary Shares
NASDAQ:RZLV
|
$594.25 Million |
|
Sundiro Holding Co Ltd
SHE:000571
|
$594.31 Million |
|
Complete Logistic Services Bhd
KLSE:5136
|
$594.31 Million |
|
Zhejiang Tianzhen Technology Co. Ltd. A
SHE:301356
|
$593.27 Million |
|
Sichuan Mingxing Electric Power Co Ltd
SHG:600101
|
$593.25 Million |
|
Zhejiang Talent Television&Film Co Ltd
SHE:300426
|
$593.15 Million |
|
BRASKEM PFD ADR/2 O.N.
F:BRD
|
$593.02 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DRI Healthcare Trust's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 561,497,000 to 527,531,000, a change of -33,966,000 (-6.0%).
- Net loss of 3,364,000 reduced equity.
- Dividend payments of 33,598,000 reduced retained earnings.
- Share repurchases of 3,917,000 reduced equity.
- New share issuances of 20,441,000 increased equity.
- Other comprehensive income decreased equity by 1,060,999.
- Other factors decreased equity by 12,467,001.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.36 Million | -0.64% |
| Dividends Paid | $33.60 Million | -6.37% |
| Share Repurchases | $3.92 Million | -0.74% |
| Share Issuances | $20.44 Million | +3.87% |
| Other Comprehensive Income | $-1.06 Million | -0.2% |
| Other Changes | $-12.47 Million | -2.36% |
| Total Change | $- | -6.05% |
Book Value vs Market Value Analysis
This analysis compares DRI Healthcare Trust's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.24x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.06x to 1.24x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $10.94 | $11.62 | x |
| 2022-12-31 | $9.65 | $11.62 | x |
| 2023-12-31 | $12.58 | $11.62 | x |
| 2024-12-31 | $9.37 | $11.62 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DRI Healthcare Trust utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.64%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.41%
- • Asset Turnover: 0.14x
- • Equity Multiplier: 1.87x
- Recent ROE (-0.64%) is below the historical average (4.92%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.14K |
| 2021 | 5.69% | 29.40% | 0.17x | 1.15x | $-16.34 Million |
| 2022 | 3.11% | 14.52% | 0.13x | 1.70x | $-25.64 Million |
| 2023 | 16.44% | 42.34% | 0.26x | 1.49x | $36.15 Million |
| 2024 | -0.64% | -2.41% | 0.14x | 1.87x | $-56.12 Million |
Industry Comparison
This section compares DRI Healthcare Trust's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $334,690,341
- Average return on equity (ROE) among peers: -98.65%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DRI Healthcare Trust (DHT-U) | $503.60 Million | 0.00% | 0.92x | $593.86 Million |
| Aurora Cannabis Inc (ACB) | $662.35 Million | -259.32% | 0.64x | $327.31 Million |
| Amotiv Limited (AOV) | $979.72 Million | 1.89% | 0.01x | $576.83 Million |
| Aequus Pharmaceuticals Inc (AQS) | $1.27 Million | -380.19% | 0.59x | $479.73K |
| Avicanna Inc (AVCN) | $-29.76K | 0.00% | 0.00x | $10.69 Million |
| Avant Brands Inc (AVNT) | $36.41 Million | -26.83% | 0.24x | $5.80 Million |
| Bausch Health Companies Inc (BHC) | $1.30 Billion | 15.07% | 0.37x | $3.09 Billion |
| CanadaBis Capital Inc (CANB) | $3.43 Million | -156.92% | 2.65x | $1.53 Million |
| Cannabist Company Holdings Inc (CBST) | $286.95 Million | -35.14% | 1.54x | $12.41 Million |
| Cipher Pharmaceuticals Inc (CPH) | $54.26 Million | 3.26% | 1.02x | $240.29 Million |
| Cardiol Therapeutics Inc Class A (CRDL) | $24.73 Million | -148.32% | 0.29x | $121.18 Million |
About DRI Healthcare Trust
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.